Assessment of Self-medication Practices During COVID-19 Pandemic in Hyderabad and Karachi, Pakistan
Abstract
Background: Lack of appropriate treatment for COVID-19 infection led the general
population of Pakistan toward self-medication and symptomatic treatment; almost
80% of the population collected medications for future use during pandemic. Thus,
the current study aimed to assess the use of medication as symptomatic treatment
preventive strategy.
Methods: This descriptive cross–sectional study was conducted on a local population
of Hyderabad and Karachi, Sindh, Pakistan. The study duration was six months (April–
September 2020). A total of 698 responders were selected via random sampling
method. The number of participants were recruited based on 95% confidence interval
with 5% margin error. Data were transferred into analysis sheet descriptively.
Results: Most participants responded to the use of different over-the-counter (OTC)
products for headache. The use of antibiotics with prescription due to allergic
conditions, cough, respiratory tract infections including sore throat, and urinary tract
infections was also found among the majority. Few respondents had self-medication
practice with sedatives due to difficulty in falling asleep, and 9.5% had self-medication
practice due to pain. About 20.8% of the population agreed that lockdown was a
contributing factor in the self-medication practice.
Conclusion: Pharmacists and healthcare professionals are advised to counsel the
general public regarding the use of medication. A close collaboration is required at
this stage to fight against COVID-19 and preventing the situation from worsening.
References
pandemic: challenges and opportunities. Drugs & Therapy Perspectives, vol. 36,
no. 12, pp. 565–567.
[2] Quispe-Cañari, J. F., Fidel-Rosales, E., Manrique, D., et al. (2021). Self-medication
practices during the COVID-19 pandemic among the adult population in Peru: a
cross-sectional survey. Saudi Pharmaceutical Journal, vol. 29, no. 1, pp. 1–11.
[3] Daniel, J. (2020). Education and the COVID-19 pandemic. Prospects, vol. 49, no. 1,
pp. 91–96.
[4] Onchonga, D. (2020). A Google Trends study on the interest in self-medication during
the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharmaceutical
Journal: SPJ, vol. 28, no. 7, p. 903.
[5] Molento, M. B. (2020). COVID-19 and the rush for self-medication and self-dosing
with ivermectin: a word of caution. One Health, vol. 10, 100148.
[6] Sadio, A. J., Gbeasor-Komlanvi, F. A., Konu, R. Y., et al. (2021). Assessment of selfmedication
practices in the context of the COVID-19 outbreak in Togo. BMC Public
Health, vol. 21, no. 1, pp. 1–9.
[7] Sahanic, S., Boehm, A., Pizzini, A., et al. (2020). Assessing self-medication for
obstructive airway disease during COVID-19 using Google Trends. European
Respiratory Journal, vol. 56, no. 5, 2002851.
[8] Watkins, J. (2020). Preventing a covid-19 pandemic. BMJ, vol. 368, m810.
[9] Nicola, M., Alsafi, Z., Sohrabi, C., et al. (2020). The socio-economic implications of
the coronavirus and COVID-19 pandemic: a review. International Journal of Surgery,
vol. 78, pp. 185–193.
[10] Van Bavel, J. J., Baicker, K., Boggio, P. S., et al. (2020). Using social and behavioural
science to support COVID-19 pandemic response. Nature human behaviour, 4(5),
460-471.
[11] Omer, S. B., Malani, P., and Del Rio, C. (2020). The COVID-19 pandemic in the US: a
clinical update. JAMA, vol. 323, no. 18, pp. 1767–1768.
[12] Karbownik, M. S., Dobielska, M., Paul, E., et al. (2020). Health-, medication-and dietary
supplement-related behaviors and beliefs relatively unchanged during the COVID-19
pandemic lockdown. Research in Social and Administrative Pharmacy.
[13] Ruiz, M. E. (2010). Risks of self-medication practices. Current Drug Safety, vol. 5, no.
4, pp. 315–323.
[14] Figueiras, A., Caamano, F., and Gestal-Otero, J. J. (2000). Sociodemographic factors
related to self-medication in Spain. European Journal of Epidemiology, vol. 16, no. 1,
pp. 19–26.
[15] Awad, A., Eltayeb, I., Matowe, L., et al. (2005). Self-medication with antibiotics and
antimalarials in the community of Khartoum State, Sudan. Journal of Pharmacy and
Pharmaceutical Sciences, vol. 8, no. 2, pp. 326–331.
[16] Afolabi, A. O. (2008). Factors influencing the pattern of self-medication in an adult
Nigerian population. Annals of African medicine, vol. 7, no. 3, pp. 120–127.
[17] Mainous, A. G., Diaz, V. A., & Carnemolla, M. (2008). Factors affecting Latino adults’
use of antibiotics for self-medication. The Journal of the American Board of Family
Medicine, vol. 21, no. 2, pp. 128–134.
[18] Selvaraj, K., Kumar, S. G., and Ramalingam, A. (2014). Prevalence of self-medication
practices and its associated factors in Urban Puducherry, India. Perspectives in
Clinical Research, vol. 5, no. 1, p. 32.
[19] Abasaeed, A., Vlcek, J., Abuelkhair, M., et al. (2009). Self-medication with antibiotics
by the community of Abu Dhabi Emirate, United Arab Emirates. The Journal of
Infection in Developing Countries, vol. 3, no. 7, pp. 491–497.
[20] Karimy, M., Rezaee-Momtaz, M., Tavousi, M., et al. (2019). Risk factors associated
with self-medication among women in Iran. BMC Public Health, vol. 19, no. 1, pp. 1–7.
[21] Lukovic, J. A., Miletic, V., Pekmezovic, T., et al. (2014). Self-medication practices and
risk factors for self-medication among medical students in Belgrade, Serbia. PloS
ONE, vol. 9, no. 12, e114644.
obstructive airway disease during COVID-19 using Google Trends. European
Respiratory Journal, vol. 56, no. 5, 2002851.
[22] Mansuri, F. M., Zalat, M. M., Khan, A. A., et al. (2020). Estimating the public
response to mitigation measures and self-perceived behaviours towards the COVID-
19 pandemic. Journal of Taibah University Medical Sciences, vol. 15, no. 4, pp. 278–
283.
